Skip to main content

Table 2 Repeated measures linear regression analysis using pre-hemodialysis supine blood pressure as the primary outcome variable (n = 54)

From: Hyperphosphatemia and its relationship with blood pressure, vasoconstriction, and endothelial cell dysfunction in hypertensive hemodialysis patients

 

Model 1

Model 2

Estimate (SE)

p-value

Estimate (SE)

p-value

Systolic Blood Pressure

 Intercept

150.0 (16)

 < .0001

147 (17)

 < .0001

 Phosphate (mg/dL)

3.82 (2.0)

.06

3.82 (2.0)

.06

 Parathyroid hormone (ng/L)

-

-

0.002 (0.003)

.9

 Interdialytic Weight Gain as percentage of body weight

-

-

0.78 (1.0)

.5

Diastolic Blood Pressure

 Intercept

84.3 (9.7)

 < .0001

85.4 (10)

 < .0001

 Phosphate (mg/dL)

4.22 (1.1)

.0002

4.31 (6.7)

.0002

 Parathyroid Hormone (ng/L)

-

-

-0.002 (0.002)

.4

 Interdialytic Weight Gain as percentage of body weight

-

-

0.16 (0.7)

.8

  1. While not present, all models also controlled for age, sex, race, ethnicity, diabetes, and the subsequent BP measurements (pre and post-HD seated, and post-HD supine)